Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial.
Saved in:
| Title: | Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial. |
|---|---|
| Authors: | Bellingan, G.1 (AUTHOR) geoff.bellingan1@nhs.net, Jacono, F.2 (AUTHOR), Bannard-Smith, J.3 (AUTHOR), Brealey, D.1 (AUTHOR), Meyer, N.4 (AUTHOR), Thickett, D.5 (AUTHOR), Young, D.6 (AUTHOR), Bentley, A.7 (AUTHOR), McVerry, B. J.8 (AUTHOR), Wunderink, R. G.9 (AUTHOR), Doerschug, K. C.10 (AUTHOR), Summers, C.11 (AUTHOR), Rojas, M.8 (AUTHOR), Ting, A.12 (AUTHOR), Jenkins, E. D.12 (AUTHOR) |
| Source: | Intensive Care Medicine. Jan2022, Vol. 48 Issue 1, p36-44. 9p. 1 Diagram, 3 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03424642 |
|---|---|
| DOI: | 10.1007/s00134-021-06570-4 |
